OpenURL Connection Search - EBSCO

Connecting you to content on EBSCOhost

Select item for more details and to access through your institution.

Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials.
Published in:
British Journal of Dermatology, 2020, v. 183, n. 2, p. 242, doi. 10.1111/bjd.18898
By:
- Simpson, E.L.;
- Lacour, J.‐P.;
- Spelman, L.;
- Galimberti, R.;
- Eichenfield, L.F.;
- Bissonnette, R.;
- King, B.A.;
- Thyssen, J.P.;
- Silverberg, J.I.;
- Bieber, T.;
- Kabashima, K.;
- Tsunemi, Y.;
- Costanzo, A.;
- Guttman‐Yassky, E.;
- Beck, L.A.;
- Janes, J.M.;
- DeLozier, A.M.;
- Gamalo, M.;
- Brinker, D.R.;
- Cardillo, T.
Publication type:
Article
Impact of baricitinib in combination with topical steroids on atopic dermatitis symptoms, quality of life and functioning in adult patients with moderate‐to‐severe atopic dermatitis from the BREEZE‐AD7 Phase 3 randomized trial.
Published in:
Journal of the European Academy of Dermatology & Venereology, 2021, v. 35, n. 7, p. 1543, doi. 10.1111/jdv.17278
By:
- Wollenberg, A.;
- Nakahara, T.;
- Maari, C.;
- Peris, K.;
- Lio, P.;
- Augustin, M.;
- Silverberg, J.I.;
- Rueda, M.J.;
- DeLozier, A.M.;
- Pierce, E.;
- Yang, F.E.;
- Sun, L.;
- Ball, S.;
- Tauber, M.;
- Paul, C.
Publication type:
Article